Rebif® (interferon beta-1a) is a treatment for your relapsing multiple sclerosis (RMS) that delivers proven efficacy and a well-established safety profile.

Learn about Rebif® (interferon beta-1a) a treatment for relapsing multiple sclerosis. See how it is thought to work and how it may reduce the activity of cells that are attacking your nervous system.

Talk to your healthcare provider about which Rebif® (interferon beta-1a) injection and dosing options are right for you.

Rebif is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Learn about the well-established safety profile and possible side effects when discussing Rebif® (interferon beta-1a) with your healthcare provider as a potential RMS treatment.

Rebif is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Rebif is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Find answers to common questions about Rebif® (interferon beta-1a) and relapsing multiple sclerosis (RMS).

The financial support specialists from MS LifeLines® are commited to finding affordable options for you to start and stay on Rebif® (interferon beta-1a).

Rebif ® (interferon beta-1a) is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive …